Bluebird Bio (NQ: BLUE )
0.6887
+0.0117
(+1.73%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Press Releases about Bluebird Bio
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20240328760605/en/1138077/5/RGRD_Logo_BusinessWire.jpg)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg)
![](https://mms.businesswire.com/media/20240327668054/en/478343/5/GPM_Logo_Colo.jpg)
![](http://www.newmediawire.com/media/sites/270/images/social-image.jpg)
Via NewMediaWire
Via TheNewswire.com
![](https://mms.businesswire.com/media/20240327881341/en/765953/22/Close_Up_Logo_HD_Blue.jpg)
![](https://mms.businesswire.com/media/20240327673565/en/1164042/5/July_30%2C_2021_-_ROSEN_LOGO.jpg)
Via NewMediaWire
Via TheNewswire.com
![](https://mms.businesswire.com/media/20240326211450/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
![](https://mms.businesswire.com/media/20240325541893/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
![](https://mms.businesswire.com/media/20240318783958/en/670463/5/bluebird_logo.jpg)
![](https://mms.businesswire.com/media/20240311251950/en/670463/5/bluebird_logo.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240305210324_beam-therapeutics-bolts-higher-on-gene-therapy-lic.jpg)
![](https://www.marketbeat.com/images/MarketBeat-icon-256x256.png)
![](https://www.marketbeat.com/logos/articles/med_20240229085127_bluebird-bio-stock-signals-potential-to-be-a-multi.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240226142303_bluebird-bio-how-to-play-leaps-options-for-growth.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240226141222_bluebird-stock-is-ripe-for-a-400-institutional-sho.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240225182115_is-crispr-therapeutics-the-nvidia-of-gene-editing.jpg)
Is CRISPR Therapeutics the NVIDIA of gene editing?
February 26, 2024
Via MarketBeat
Topics
Artificial Intelligence
![](https://www.marketbeat.com/logos/articles/med_20240212110357_gene-therapy-why-does-it-cost-millions-for-a-singl.jpg)
![](https://www.marketbeat.com/logos/articles/med_20240108072132_2-low-priced-gene-therapy-stocks-to-speculate-on.jpg)
![](https://mms.businesswire.com/media/20240108221653/en/670463/5/bluebird_logo.jpg)
![](https://mms.businesswire.com/media/20240102188681/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
From bluebird bio, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20231219687449/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
bluebird bio, Inc. Announces Pricing of $125 Million Public Offering of Common Stock
December 19, 2023
From bluebird bio, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20231218251755/en/724732/5/Full_Color_Logo_Bluebird-Logo-full-color.jpg)
bluebird bio, Inc. Announces Proposed Public Offering of Common Stock
December 18, 2023
From bluebird bio, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.